Finance

Beta
Senarai
Sektor ekuiti
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Buka
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.13%
1,095.26
+1.45
+0.13%
—1,093.811,096.521,100.221,093.20——
SIXC
Communications
SIXC
Communications
SIXC
+0.34%
610.83
+2.06
+0.34%
—608.77608.77612.97608.77——
SIXE
Energy
SIXE
Energy
SIXE
-1.15%
1,240.42
-14.39
-1.15%
—1,254.811,253.011,253.871,226.33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.66%
1,749.44
-11.67
-0.66%
—1,761.111,764.271,766.881,745.39——
SIXM
Financials
SIXM
Financials
SIXM
-0.09%
642.01
-0.57
-0.09%
—642.58644.87648.48641.40——
SIXR
Staples
SIXR
Staples
SIXR
-0.24%
849.07
-2.06
-0.24%
—851.13855.66858.75845.56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.23%
217.47
-0.51
-0.23%
—217.98217.98218.65216.88——
SIXT
Technology
SIXT
Technology
SIXT
+1.63%
3,264.16
+52.33
+1.63%
—3,211.833,227.213,267.763,226.55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.50%
944.23
-4.75
-0.50%
—948.98948.58957.83941.97——
SIXV
Health care
SIXV
Health care
SIXV
-0.23%
1,471.11
-3.41
-0.23%
—1,474.521,479.031,481.041,469.17——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.64%
2,407.35
+15.23
+0.64%
—2,392.122,396.952,421.222,382.32——
SCNI:NASDAQ
Scinai Immunotherapeutics Ltd - ADR
USD 0.71
-4.66%
(-0.035) 1H
1 Mei, 3:17:02 PTG GMT-4  ·   USD
Semua simbol
SimbolPriceChange% Change
Generating top insights for SCNI...
Buka
USD 0.69
High
USD 0.74
Low
USD 0.68
Mkt. cap
2.49J
Avg. vol.
43.52K
Volume
119.82K
52-wk high
USD 6.18
52-wk low
USD 0.54
EPS
-USD 3.56
Beta
1.98
Shares outstanding
3.54J
No. of employees
45
News stories
From sources across the web
Profil
BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis. Wikipedia
About Scinai Immunotherapeutics Ltd - ADR
CEO-
Employees45
Founded1 Jan 2003
Headquarters-
Sector-
Websitescinai.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mac 2025
Jun 2025
Sep 2025
Dis 2025
Revenue
386.50K
386.50K
269.00K
269.00K
Cost of goods sold
1.02J
1.02J
960.00K
960.00K
Cost of revenue
1.02J
1.02J
960.00K
960.00K
Research and development expenses
618.50K
618.50K
566.00K
566.00K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
628.00K
628.00K
632.50K
632.50K
Operating expense
1.25J
1.25J
1.20J
1.20J
Total operating expenses
2.27J
2.27J
2.16J
2.16J
Operating income
-1.88J
-1.88J
-1.89J
-1.89J
Other non operating income
-
-
-3.50K
-3.50K
EBT including unusual items
-2.07J
-2.07J
-2.09J
-2.09J
EBT excluding unusual items
-2.07J
-2.07J
-2.09J
-2.09J
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.07J
-2.07J
-2.09J
-2.09J
Net profit margin
-534.80%
-534.80%
-775.65%
-775.65%
Earnings per share
-
-
-
-
Interest and investment income
-
-
16.00K
16.00K
Interest expense
-185.50K
-185.50K
-
-
Net interest expenses
-185.50K
-185.50K
16.00K
16.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.53J
-1.53J
-1.53J
-1.53J
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

Tugasan saya
Anda belum membuat tugasan lagi
Tugasan anda akan dipaparkan di sini. Jadualkan tugasan dan manfaatkan Google Finance semasa anda tiada.
Templat
Ringkasan senarai amatan
Analisis prapasaran harian bagi senarai amatan anda
Pendapatan Akan Datang
Laporan pendapatan akan datang dalam minggu ini
Kemudahubahan & Jumlah yang Tidak Normal
Amaran awal kemudahubahan dan jumlah hari ini
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer